Market
Cytokinetics, Incorporated
Buy
Sell
One time
USD
CYTK
≈
0.15537601
CYTK
$50
$150
$500
Pay with
Google Pay
Apple Pay
USD Account
1-2 business days • No fees
Credit/debit card
Instant •
2.99%
0% fee first 30 days
Market
Cytokinetics, Incorporated
Buy
Sell
One time
USD
CYTK
≈
0.15537601
CYTK
$50
$150
$500
Pay with
Google Pay
Apple Pay
USD Account
1-2 business days • No fees
Credit/debit card
Instant •
2.99%
0% fee first 30 days
CYTK
$64.36
-2.98%
Rank
#13345
All-time high
$90.00
-39.84%
All-time low
$60.06
6.68%
Cytokinetics is a biopharmaceutical company focused on cancer and cardiovascular disease treatment. Co.'s drug candidate, SB-715992, is a Phase II clinical trials program conducted by its partner GlaxoSmithKline and the National Cancer Institute.
Make investing stress-free
Trade with deep liquidity and low fees
| Time | Price | Change |
|---|---|---|
| Today | 0.00% | |
| 1 day | -$1.98 (2.98%) | |
| 1 week | -$4.71 (6.10%) | |
| 1 month | -$8.16 (10.84%) | |
| 1 year | -$12.59 (13.79%) |
